Navigation Links
Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy
Date:4/27/2009

lowed by monthly maintenance doses of 80 mg. Degarelix is available for order through traditional and specialty pharmacy distributors. The average monthly cost of one year of degarelix treatment is comparable to other hormone treatments for prostate cancer.

The most commonly observed adverse reactions during degarelix therapy included injection site reactions (e.g. pain, erythema, swelling or induration), hot flashes, increased weight, fatigue, and increases in serum levels of transaminases and gamma-glutamyltransferase (GGT). Ninety-nine percent of these observed adverse reactions were Grade 1 or 2 (mild to moderate). Specifically relating to the injection site adverse reactions, most were transient, of mild to moderate intensity, occurred primarily with the starting dose and led to few discontinuations (<1%). Grade 3 (severe) injection site reactions occurred in two percent or less of patients receiving degarelix.

Degarelix is contraindicated in patients with known hypersensitivity to degarelix or to any of the product components. Degarelix is not indicated in women or pediatric patients. Long-term androgen deprivation therapy prolongs the QT interval. Physicians should consider whether the benefits of androgen deprivation therapy outweigh the potential risks in patients with congenital long QT syndrome, electrolyte abnormalities, or congestive heart failure and in patients taking Class IA (e.g. quinidine, procainamide) or Class III (e.g. amiodarone, sotalol) antiarrhythmic medications.

About Prostate Cancer

Prostate cancer is the most common cancer, excluding skin cancers, and the second leading cause of cancer death in American men. About one man in six will be diagnosed with prostate cancer during his lifetime, and one in 35 will die of this disease.(4) Prostate cancer develops from cells in the prostate gland that begin to grow out of control. In most cases, prostate cancer grow
'/>"/>

SOURCE Ferring Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. deCODE and Radboud University Discover Common Variants in the Human Genome Conferring Risk of Bladder Cancer
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
6. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
7. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
11. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... commands the vital signs monitoring devices market with ... . The North American and European vital signs ... $907.0 million, respectively, by the end of 2013. They ... rising number of elderly people across these economies. The ... demand owing to the rising demand for home health ...
(Date:9/2/2014)... Reportlinker.com announces that a new market ... Acute Heart Failure Global Clinical Trials Review, ... Acute Heart Failure Global Clinical Trials ... clinical trial report, "Acute Heart Failure Global Clinical ... Acute Heart Failure clinical trial scenario. This report ...
(Date:9/2/2014)... 2014   Santa Clara dentist , Dr. ... for Invisalign. Invisalign is an orthodontic system that uses ... often the orthodontic treatment of choice for older teens ... it. For a limited time, patients can try Invisalign ... the usual cost. This offer cannot be combined, and ...
Breaking Medicine Technology:Market of Vital Signs Monitoring Devices Forecast to 2018 2Market of Vital Signs Monitoring Devices Forecast to 2018 3Acute Heart Failure Global Clinical Trials Review, H2, 2014 2Acute Heart Failure Global Clinical Trials Review, H2, 2014 3Acute Heart Failure Global Clinical Trials Review, H2, 2014 4Acute Heart Failure Global Clinical Trials Review, H2, 2014 5Acute Heart Failure Global Clinical Trials Review, H2, 2014 6Acute Heart Failure Global Clinical Trials Review, H2, 2014 7Acute Heart Failure Global Clinical Trials Review, H2, 2014 8Santa Clara Cosmetic Dentist, Dr. Alan Frame, is Now Offering a Special on Invisalign 2
... 2007 - CELSION CORPORATION,(AMEX:CLN) today announced the ... using ThermoDox(R), to treat non-resectable liver,cancer. The ... Research,and Development Agreement (CRADA) was performed at ... Institutes of Health, under,the leadership of Dr. ...
... NEW YORK--(BUSINESS WIRE)--May 30, 2007 - INNOVIVE ... data from a Phase I,trial of INNO-406, ... for Gleevec(R)-resistant or,treatment-intolerant chronic myelogenous leukemia, will ... Clinical Oncology Annual,Meeting. The meeting takes place ...
Cached Medicine Technology:Celsion Completes Enrollment in Phase I Liver Cancer Study 2Celsion Completes Enrollment in Phase I Liver Cancer Study 3Innovive Pharmaceuticals to Present Interim Data from Phase I Study,of INNO-406 at the American Society of Clinical Oncology Annual,Meeting 2
(Date:9/2/2014)... York, NY (PRWEB) September 02, 2014 ... soccer tickets. The first week in September will be ... Teams from Brazil, Colombia, Mexico, Chile, Ecuador and Bolivia ... The following matches will take place between September 5th - ... Stadium on Tuesday, September 9th , Mexico vs. ...
(Date:9/2/2014)... NY (PRWEB) September 02, 2014 The ... VisitandCare.com , was designed to help doctors manage foreign ... to boost patient conversion rates and clink revenue. Since ... 60 percent increase in sales revenue and a 70 ... CRM software in their own healthcare practices. , With ...
(Date:9/2/2014)... you are hospitalized, but your outpatient doctor does ... office for follow-up care, but your doctor does ... stay? Missing or incomplete communication from hospitals ... to poor experiences and lead to hospital readmissions. ... implementing guidelines can improve hospitals, communication during patient ...
(Date:9/2/2014)... Experimental Biology and Medicine that appears ... and medicine of microphysiological systems" and describes the ... Program directed by the National Center for Advancing ... Health (NIH) and funded in part by the ... Agency (DARPA) and the Food and Drug Administration ...
(Date:9/2/2014)... Ohio (PRWEB) September 02, 2014 For ... managed IT security and network services company, has been ... nation. Inc. magazine's Inc. 5000 list highlights America's fastest ... each year since the list inception in 2007. , ... has grown 144 percent over the past three years. ...
Breaking Medicine News(10 mins):Health News:Ticket Down Substantially Slashes Ticket Prices on Brazil vs. Ecuador Tickets, Brazil vs. Colombia Tickets, Mexico vs. Chile Tickets and Mexico vs. Bolivia Tickets 2Health News:Ticket Down Substantially Slashes Ticket Prices on Brazil vs. Ecuador Tickets, Brazil vs. Colombia Tickets, Mexico vs. Chile Tickets and Mexico vs. Bolivia Tickets 3Health News:Doctors Abroad Using VisitandCare.com Patient Management Software Report 60% Increase in Revenue 2Health News:Doctors Abroad Using VisitandCare.com Patient Management Software Report 60% Increase in Revenue 3Health News:Doctors Abroad Using VisitandCare.com Patient Management Software Report 60% Increase in Revenue 4Health News:Can data motivate hospital leaders to improve care transitions? 2Health News:Microphysiological systems will revolutionize experimental biology and medicine 2Health News:Microphysiological systems will revolutionize experimental biology and medicine 3Health News:CentraComm Named to Inc. 5000 for 8th Consecutive Year 2
... battle super bugs, including MRSA, has found its way to ... as Tygacil, is one of the few new antibiotics to ... ,Micro organisms have undergone mutations that enabled them ... infections, such as MRSA, in hospitals. ,The new ...
... new study suggests that male circumcision could significantly reduce ... findings that has been published in the Journal PLoS ... that suggested circumcision reduced HIV infection risk in heterosexual ... researchers have used that data and conducted the research, ...
... study in the July issue of Archives of General Psychiatry, ... fact more prone to depression. //The study on more than ... percent increased risk of developing mood and anxiety disorders including, ... is an important public health issue because both of these ...
... agreed to reconduct lab tests to find out whether a ... as early as 2003, after eight of its scientists alleged ... Ministry of Health said it was conducting new lab tests ... ,"In accordance with World Health Organisation and China's diagnostic standards ...
... compares two common inhalers for patients suffering from ... reduces respiratory-related hospitalizations and respiratory deaths, but the ... of cases -- increases respiratory deaths. ... 22 trials with 15,276 participants found that common ...
... Researchers at the Institute Of Cancer Research have discovered a ... the disease.// ,It is found that if a ... being diagnosed with breast cancer doubles. This would serve as ... risk of cancer and thereby help treat and prevent the ...
Cached Medicine News:Health News:New Drugs To Combat Mutant Bugs 2Health News:Practise Of Male Circumcision In Africa May Reduce HIV Risks 2Health News:COPD Patients Using Beta-agonist Inhalers Are at Risk 2
Exidine® 2% CHG Brushless Surgical Scrub offers exceptional persistence and broad-spectrum antimicrobial activity....
... FDA approved, Avagard antiseptic hand prep ... hand scrub brushes and antimicrobial soaps. ... hands for surgery, it's fast-acting and ... for up to six hours without ...
... antimicrobial skin cleanser will not leave your ... frequent washings. With persistent Antimicrobial action, CHG ... microorganisms, including gram-negative and gram-positive bacteria, fungi, ... a 15 second hand wash. The solution ...
Upon application to intact skin, Skin-Prep* protective wipes forms a protective film that prepares the skin for the attachment of drainage tubes, external catheters, adhesive dressings and can be...
Medicine Products: